Ion Beam Applications SA IBA (($GB:0GZK)) announced an update on their ongoing clinical study. Ion Beam Applications SA (IBA) is conducting a ...

Ladies and gentlemen, welcome to the IBA Web Conference. I am pleased to present Mr. Olivier Legrain, CEO; and Madam Soumya Chandramouli, CFO. For the first part of this call, let me remind you that, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

The advent of helium ion microscopy (HIM) has revolutionised nanoscale imaging and fabrication by offering unparalleled resolution and minimal sample damage. This technique utilises a focused beam of ...

Ion Beam Applications SA (IBAB) reported a robust performance for the second quarter of 2025, achieving a 40% revenue increase compared to the first half of 2024. Despite a net loss of €2.6 million, ...

The average one-year price target for Ion Beam Applications (EBR:IBAB) has been revised to 24.53 / share. This is an increase of 9.15% from the prior estimate of 22.47 dated July 5, 2023. The price ...

@RyanMFierce: AbbVie is forking over $70 million upfront in collab with Alvine for PhII drug against Celiac disease. Release | Follow @RyanMFierce > Biogen Idec is on a roll. Shortly after winning an ...

The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), has recently been designated as an International Atomic Energy Agency ...

Ladies and gentlemen, welcome to the IBA web conference. I am pleased to present Mr. Olivier Legrain, CEO; and Madam Soumya Chandramouli, CFO, for the first part of this call. [Operator Instructions].

Ion Beam Applications S.A. Annual stock financials by MarketWatch. View the latest IBAB financial statements, income statements and financial ratios.